Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to quantitate Central Nervous System (CNS) autoantibody development in human blood using ELISA after human brain injury, spinal cord injury, and intra-axial brain surgeries.


Clinical Trial Description

Study Objectives:

We aim to:

1. Quantitate CNS autoantibody development in human blood using ELISA after human brain injury, spinal cord injury, and intra-axial brain surgeries. We also aim to characterize the temporal course of this response.

2. Characterize how CNS autoantibody levels correlate with specific injury patterns as well as radiographic and clinical measures of injury severity.

3. Determine how intercurrent infection and a history of prior CNS insult affects the temporal course and magnitude of autoantibody production. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03089749
Study type Observational
Source University of Utah
Contact Gregory WJ Hawryluk, MD, Ph.D.
Phone 801-581-6908
Email gregory.hawryluk@hsc.utah.edu
Status Recruiting
Phase
Start date May 2015
Completion date May 2022

See also
  Status Clinical Trial Phase
Recruiting NCT03504709 - REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness
Not yet recruiting NCT03648476 - Intervention to Change Attributions That Are Negative (ICAN) N/A
Completed NCT02426749 - Treatment and Recovery Monitoring of Post TBI Symptoms N/A
Completed NCT01339702 - The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
Recruiting NCT03727737 - Efficacy of Repetitive Transcranial Magnetic Stimulation for Improvement of Memory in Older Adults With TBI N/A
Recruiting NCT03153397 - Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial) N/A
Not yet recruiting NCT02776488 - Metabolic Therapy for Traumatic Brain Injury Phase 1/Phase 2
Recruiting NCT02004080 - CREACTIVE - Collaborative REsearch on ACute Traumatic Brain Injury in intensiVe Care Medicine in Europe
Completed NCT01336413 - Neuroactive Steroids and Traumatic Brain Injury (TBI) in OEF/OIF Veterans Phase 2
Recruiting NCT03671083 - Validation of Brain Function Assessment Algorithm for mTBI From Initial Injury to Rehabilitation
Enrolling by invitation NCT02525432 - Autologous Stem Cell Study for Adult TBI (Phase 2b) Phase 2
Not yet recruiting NCT03429322 - Medical and Resource Facilitation Intervention After Traumatic Brain Injury N/A
Enrolling by invitation NCT02652598 - Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD Phase 2
Active, not recruiting NCT02158494 - Noninvasive Neuromodulation for Treatment of Symptoms Due to Mild or Moderate Traumatic Brain Injury N/A
Active, not recruiting NCT01417468 - How Well do Patients With Traumatic Brain Injury Learn New Material Using Learning Styles in Online Science Classrooms? N/A
Terminated NCT00316004 - Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI) Phase 3
Recruiting NCT02920788 - Mild TBI Assessment & Rehabilitation N/A
Recruiting NCT03068143 - Postoperative Temperature Monitoring In Brain Trauma N/A
Completed NCT00961779 - Safety Study of NNZ-2566 in Healthy Female Subjects Phase 1
Recruiting NCT03515967 - Testing Mild Traumatic Brain Injury (mTBI) in Diverse Athletic Groups N/A